Cherry Cepacol Sore Throat Lozenges recall: Subpotent
Cherry Cepacol Sore Throat Lozenges, Benzocaine 15 mg | Menthol 3.6 mg, a)16-count, NDC 63824-711-16 b) Institutional Size, 576-count, NDC…
Why was Cherry Cepacol Sore Throat Lozenges recalled?
Subpotent Drug: Product did not conform to the 18-month stability test specification for active Free Benzocaine.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
16 count: AG156 Exp 11/13, AG257 Exp 12/13, AH388 02/14, AJ167 03/14, AL367 Exp 05/14, AL555 & AL568 Exp 06/14, AM141 Exp 07/14. 576 Count: AK505 Exp 04/14, AK570 Exp 05/14, AH368 & AH398 Exp 02/14, AJ000 Exp 03/14, AG596 Exp 12/13,
- Product
- Cherry Cepacol Sore Throat Lozenges, Benzocaine 15 mg | Menthol 3.6 mg, a)16-count, NDC 63824-711-16 b) Institutional Size, 576-count, NDC…
- Recalling firm
- Reckitt Benckiser Inc
- Quantity
- 27,718 cases 16 count and 7,551 cases 576 count
- Distribution
- Nationwide
- Recall date
- May 8, 2013
- Classification
- Class III
- Status
- Terminated
- Agency
- FDA (drug)